Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Change-In-Working-Capital" stands at -8.33 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.
Chugai Pharmaceutical Co. Ltd.'s third quarter result of -33.58 Billion JPY for the item "Change In Working Capital" represents a decrease of -36.10 percent compared to it's second quarter result.
Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of -33.58 Billion JPY for the item "Change In Working Capital" represents a decrease of -216.00 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of -8.33 Billion JPY for the item "Change In Working Capital" represents a decrease of -115.38 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 16.92 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 16.92 Billion Japanese Yens.
The 3 year change is 37.75 Billion Japanese Yens.
The 5 year change is 19.98 Billion Japanese Yens.
The 10 year change is -91.75 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change In Working Capital | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change In Working Capital | 486,508,953,600.00 |
![]() | AbbVie Inc - Change In Working Capital | 399,570,305,024.00 |
![]() | Roche Holding AG - Change In Working Capital | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change In Working Capital | 280,205,508,085.11 |